BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3012922)

  • 1. New and prospective developments in antifungal drugs.
    Cauwenbergh G
    Acta Derm Venereol Suppl (Stockh); 1986; 121():147-53. PubMed ID: 3012922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New antifungal agents in the treatment of superficial dermatomycoses].
    Degreef H
    Ann Dermatol Venereol; 1993; 120(1):21-31. PubMed ID: 8393313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-Malassezia furfur activity in vitro and in experimental dermatitis of six imidazole antifungal agents: bifonazole, clotrimazole, flutrimazole, ketoconazole, miconazole and sertaconazole.
    Van Gerven F; Odds FC
    Mycoses; 1995; 38(9-10):389-93. PubMed ID: 8569815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allylamines: topical and oral treatment of dermatomycoses with a new class of antifungal agents.
    Ganzinger U; Stutz A; Petranyi G; Stephen A
    Acta Derm Venereol Suppl (Stockh); 1986; 121():155-60. PubMed ID: 3459341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind investigation of R-42470 (terconazole cream 0.4%) and clotrimazole (cream 1%) for the topical treatment of mycotic vaginitis.
    Del Palacio-Hernanz A; Sanz-Sanz F; Rodriquez-Noriega A
    Chemioterapia; 1984 Jun; 3(3):192-5. PubMed ID: 6529776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Athlete's foot.
    Crawford F
    Clin Evid; 2004 Dec; (12):2266-70. PubMed ID: 15865786
    [No Abstract]   [Full Text] [Related]  

  • 7. Topical pharmacology of imidazole antifungals.
    Holt RJ
    J Cutan Pathol; 1976; 3(1):45-59. PubMed ID: 945306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Athlete's foot.
    Crawford F
    Clin Evid; 2005 Dec; (14):2000-5. PubMed ID: 16620478
    [No Abstract]   [Full Text] [Related]  

  • 9. [Multicenter double-blind contralateral comparison of naftifin and clotrimazole cream in patients with dermatophytosis and candidiasis].
    Zaun H; Luszpinski P
    Z Hautkr; 1984 Sep; 59(18):1209-17. PubMed ID: 6388169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Imidazole preparations in mycology].
    Sheklakov ND; Rukavishnikova VM
    Vestn Dermatol Venerol; 1984 Jun; (6):51-8. PubMed ID: 6089467
    [No Abstract]   [Full Text] [Related]  

  • 11. New antifungal agents.
    Lesher JL
    Dermatol Clin; 1992 Oct; 10(4):799-805. PubMed ID: 1327600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antifungal imidazoles: clotrimazole and miconazole.
    Milne LJ
    Scott Med J; 1978 Apr; 23(2):149-52. PubMed ID: 644298
    [No Abstract]   [Full Text] [Related]  

  • 13. Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
    Odds FC; Webster CE; Abbott AB
    J Antimicrob Chemother; 1984 Aug; 14(2):105-14. PubMed ID: 6094418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Double blind, randomized in vivo investigations comparing the antifungals clotrimazole, tolnaftate and naftifine (author's transl)].
    Hantschke D; Reichenberger M
    Mykosen; 1980 Dec; 23(12):657-68. PubMed ID: 7012610
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical basis for the activity and selectivity of oral antifungal drugs.
    Vanden Bossche H; Marichal P; Gorrens J; Coene MC
    Br J Clin Pract Suppl; 1990 Sep; 71():41-6. PubMed ID: 2091733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis.
    Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2013 Nov; 12(11 Suppl):s165-71. PubMed ID: 24196340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungals: oral and topical.
    DeVillez RL; Harkless LB
    Clin Podiatr Med Surg; 1992 Apr; 9(2):275-83. PubMed ID: 1586904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis.
    Ellepola AN; Samaranayake LP
    Dent Update; 2000 May; 27(4):165-70, 172-4. PubMed ID: 11218451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naftifine versus miconazole/hydrocortisone in inflammatory dermatophyte infections.
    Nada M; Hanafi S; al-Omari H; Mokhtar M; el-Shamy S; Mühlbacher J
    Int J Dermatol; 1994 Aug; 33(8):570-2. PubMed ID: 7960355
    [No Abstract]   [Full Text] [Related]  

  • 20. Consensus of the role and positioning of the imidazoles in the treatment of dermatophytosis.
    Jones HE
    Acta Derm Venereol Suppl (Stockh); 1986; 121():139-46. PubMed ID: 2940792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.